Skip to search formSkip to main contentSkip to account menu

azimexon

Known as: AZ, 2-Cyanaziridinyl-2-carbamoyl-aziridinyl-1-propane, 2-Aziridinecarboxamide, 1-[1-(2-cyano-1-aziridinyl)-1-methylethyl] 
Azimexon (2-cyanaziridinyl-2-carbamoyl-aziridinyl-1-propane) is a derivative of 2-cyanaziridine. Immunostimulant which shows therapeutic effects in… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AziridinesImmunologic Adjuvants
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Small-Pore Zeolites: Synthesis and Catalysis.
In the past decade or so, small-pore zeolites have received greater attention than large- and medium-pore molecular sieves that… 
Highly Cited
2007
Highly Cited
2007
Three-Dimensional Architecture of Presynaptic Terminal Cytomatrix
Presynaptic terminals are specialized for mediating rapid fusion of synaptic vesicles (SVs) after calcium influx. The regulated… 
Review
2005
Review
2005
Adverse reactions to dermal fillers: review.
BACKGROUND For many patients, injectable filling agents offer the promise of facial rejuvenation while offering reduced risks… 
Highly Cited
2003
Highly Cited
2003
Revascularization of Human Acellular Dermis in Full-Thickness Abdominal Wall Reconstruction in the Rabbit Model
This study investigates whether human acellular dermis (Alloderm; LifeCell, Branchburg, NJ) revascularizes when used to… 
Highly Cited
2002
Highly Cited
2002
Calcium Secretion Coupling at Calyx of Held Governed by Nonuniform Channel–Vesicle Topography
Phasic transmitter release at synapses in the mammalian CNS is regulated by local [Ca2+] transients, which control the fusion of… 
Highly Cited
2002
Highly Cited
2002
Linear Spatial Integration for Single-Trial Detection in Encephalography
Conventional analysis of electroencephalography (EEG) and magnetoencephalography (MEG) often relies on averaging over multiple… 
Highly Cited
2001
Highly Cited
2001
Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message.
BACKGROUND Several studies have reported what seem to be false-positive results using the Food and Drug Administration (FDA… 
Highly Cited
1999
Highly Cited
1999
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer.
PURPOSE To compare fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) in the determination of HER-2/neu… 
Highly Cited
1989
Highly Cited
1989
Effects of passive immunity on subsequent production in dairy heifers.
Dairy Herd Improvement data from a large, commercial dairy farm were used to evaluate the relationships of first lactation milk… 
Highly Cited
1978
Highly Cited
1978
Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury.
Interruption of the blood supply to rat liver produces a progressive loss of phospholipids from the ischemic cells. Whole… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)